Preclinical Antitumor Activity and Toxicity of the PSMA-Docetaxel Conjugate Substance in Comparison with Docetaxel In Vivo

Shchepin N.A. ¹ , Machulkin A.E. ² , Majouga A.G.² , Smirnova G.B. , Borisova Y.A. , Pokrovsky V.S. ¹

#SCIENCE4HEALTH2021 : XII International scientific conference. Moscow, RUDN, May 21-22, 2021

РУДН

Английский

227-228

Опубликовано

2021

• ¹ RUDN University
• ² M.V. Lomonosov Moscow State University
• ³ N.N. Blokhin Cancer Research Center

Prostatic neoplasms; prostate-specific membrane antigen; docetaxel; conjugates